Diseases: Page 4

Bavarian Nordic ends cancer vaccine program
By LabPulse.com staff writers
Biotech firm Bavarian Nordic is ceasing all work on its cancer vaccine program, instead prioritizing its infectious disease projects.
February 22, 2024
Vial Vaccine Vial Tech Social
National Cancer Institute launches network to evaluate cancer screening technologies
By LabPulse.com staff writers
In support of the Biden-Harris administrationā€™s Cancer Moonshot initiative, the U.S. National Institutes of Health has launched the Cancer Screening Research Network, a clinical trial network for evaluating emerging cancer screening technologies.
February 22, 2024
Cancer Therapy Targeted Social
ā€˜Remarkableā€™ results in lupus patients spark speculation CAR-T may cure autoimmunity
By Nick Paul Taylor
The generation of ā€œremarkableā€ results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
T Cell Social
FDA grants accelerated approval to Iovanceā€™s melanoma cell therapy
By LabPulse.com staff writers
The FDA granted accelerated approval to Iovance Biotherapeuticsā€™ T-cell therapy treatment for unresectable or metastatic melanoma.
February 21, 2024
Melanoma Social
International consortium aims to develop precision approach for CVD
By Matt Limb
An international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.
February 21, 2024
Heart Pulmonary Trunk Social
CRISPR and nanopore technology enable sensitive and specific mpox detection
By Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in Biosensors and Bioelectronics.
February 16, 2024
3 D Monkeypox Infecting Cell Social
Freenome raises $254M in funding to advance cancer test pipeline
By LabPulse.com staff writers
Biotech firm Freenome has raised $254 million in new funding from new and existing investors to accelerate its pipeline of early detection cancer tests for its multiomics platform.
February 15, 2024
Research Money Social
Study: Novel type of inhibitor may prevent microvascular diabetic complications
By Matt Limb
A new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease, research suggests.
February 15, 2024
Diabetes Insulin Glucose Blood Social
Gold-enhanced nanopore sensors detect ovarian cancer biomarker in urine
By Nick Paul Taylor
Nanopore sensors that use gold nanoparticles to capture certain peptides could enable the detection of ovarian cancer biomarkers in urine samples, according to a paper published in ACS Sensors.
February 14, 2024
Ovarian Cancer2 Social
NHS lacks capacity for Alzheimerā€™s diagnostics, warn experts
By Matt Limb
Many thousands of patients in the U.K. could miss out on new treatments for Alzheimerā€™s disease because its National Health Service (NHS) lacks capacity for diagnostic tests, warn experts.
February 14, 2024
Amyloid Plaque Alzheimer2 Social
Quest Diagnostics seeks to get a jump on PFAS testing in communities
By Liz Carey
Researchers often use peopleā€™s blood PFAS levels as a proxy for exposure to perfluoroalkyl and polyfluoroalkyl substances, the "forever chemicals" found in certain products and the environment.
February 13, 2024
This U.S. Geological Survey (USGS) map shows the number of PFAS detected in tap water samples from select sites across the nation. The findings are based on a USGS study of samples taken between 2016 and 2021 from private and public supplies at 716 locations. The map does not represent the only locations in the U.S. with PFAS. (Source: USGS, public domain.)
CorDx submits EUA application for COVID-19/influenza rapid test
By LabPulse.com staff writers
CorDx has submitted an Emergency Use Authorization (EUA) application for its CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test to the U.S. Food and Drug Administration (FDA).
February 10, 2024
Influenza Virus Social
Previous Page
Page 4 of 283
Next Page